INSIGHTS ON DRUG DEVELOPMENT

• Keeping Future Manufacturing Options Open During Development

  Early choices affect manufacturing flexibility, tech transfer, and supply chain resilience. Addressing IP and production needs early helps preserve options for commercialization.

• Mobile Minor Process Explanation

  Dr. Jordan Potts explains how the Mobile Minor spray dryer works and outlines its role in spray drying and particle engineering research applications.

• How To Achieve Late-Phase Success In Complex OSD Development

  Late-phase OSD scale-up demands more than technical know-how. This paper examines the frameworks, tools, and partnership models that determine whether promising molecules reach commercial production reliably.

• An Integrated Analytical Approach To Lipase Risk Management In Biologics Development

  Conventional HCP testing cannot confirm whether residual lipases remain enzymatically active. Here, the authors examine why functional activity data are essential for managing polysorbate-related stability risk in biologics development.

• Patient-Centric Formulations In Pediatric Adherence

  11/13/2025

  Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.

• How The Accelerator™ Drug Development Model Enhances eNPV

  2/25/2026

  Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.

• Silyl Ether Linkers For Hydroxyl-Bearing Payload Conjugates

  6/19/2026

  Discover an innovative approach to drug conjugation that expands the range of molecules suitable for targeted therapies while preserving their biological activity and enabling controlled drug release.

• Compaction Simulation For Tablet Technology Transfer And Scale-Up

  7/15/2026

  Compaction simulation de-risked tech transfer for a 40 mg fexuprazan tablet by defining optimal roller compaction and lubrication parameters before scale-up. Access the full case study to see the data.

• Matrigel Dome Assay And Drug Screening Of Colorectal Cancer Organoids

  3/31/2025

  Using CRC organoids and bioprinting, explore the automation of dome assays to evaluate drug responses and delve into the insights from image-based end-point assays on the efficacy of anti-cancer treatments.